|1.||Smolensky, Michael H: 1 article (05/2014)|
|2.||Marlot, Michel: 1 article (05/2014)|
|3.||Riedel, Marc: 1 article (05/2014)|
|4.||Mauvieux, Benoit: 1 article (05/2014)|
|5.||Brousse, Eric: 1 article (05/2014)|
|6.||Touitou, Yvan: 1 article (05/2014)|
|7.||Reinberg, Alain: 1 article (05/2014)|
|8.||Berrez, Stephane: 1 article (05/2014)|
|9.||Price, Donald D: 1 article (08/2012)|
|10.||Staud, Roland: 1 article (08/2012)|
01/01/1985 - "In addition, exercise-induced tachycardia was significantly reduced by bornaprolol up to 48 hours after drug intake (pharmacodynamic half-life approximately 63-86 h) and there was a correlation between this reduction and the log plasma bornaprolol concentration over the 48-h period. "
06/01/1987 - "A correlation was also found for each group of subjects between the time course of the plasma drug concentration and the effects of each bornaprolol dose on isoproterenol- and exercise-induced tachycardia. "
01/01/1985 - "Bornaprolol significantly reduced resting heart rate, dose-dependently lowered exercise-induced tachycardia and decreased peak expiratory flow rate and plasma renin activity. "
06/01/1987 - "Bornaprolol significantly reduced the resting heart rate, isoproterenol- and exercise-induced tachycardia, and effort hypertension. "
|2.||Asthma (Bronchial Asthma)
07/01/1997 - "To investigate the facilitatory effects of acute administration of systemic corticosteroid on bronchodilator subsensitivity, as might occur in the setting of acute asthma, 12 subjects with moderately severe asthma, with a mean FEV1 of 66% predicted, of whom were all receiving inhaled corticosteriod, were randomized to receive either inhaled placebo (PL) or inhaled formoterol (FM) 24 micrograms twice daily for 4 wk in a double-blind crossover study. "
10/01/2000 - "Fifteen patients with atopic persistent asthma were evaluated (mean age, 32.4 years; FEV(1), 75.2% predicted) in a randomized, double-blind, double-dummy, placebo-controlled crossover study with a 1-week placebo washout period, comparing the following once-daily nighttime treatments: (1) formoterol (FM), 12 microg, for 2 weeks and FM, 24 microg, for 2 weeks; or (2) budesonide (BUD), 400 microg, for 2 weeks and BUD, 800 microg, for 2 weeks; or (3) FM, 12 microg, plus BUD, 400 microg, for 2 weeks and FM, 24 microg, plus BUD, 800 microg, for 2 weeks. "
|3.||Out-of-Hospital Cardiac Arrest
|5.||Hypertension (High Blood Pressure)